Nowe leki w EU – co nowego z Europejskiej Agencji Leków (EMA)
Journal Title: Alergia - Year 2018, Vol 0, Issue 2
Abstract
received a positive opinion in the years 2017 – 2018 by the CHMP of the EMA are discussed. ............................... Omówiono najnowsze produkty lecznicze zaopiniowane pozytywnie przez CHMP Europejskiej Agencji Leków w latach 2017 - 2018. Wybrano te leki które znalazły zastosowanie w leczeniu POChP, kwasochłonnego zapalenia przełyku oraz atopowego zapalenia skóry.
Authors and Affiliations
Michał Pirożyński
Keywords
Related Articles
- EP ID EP463204
- DOI -
- Views 153
- Downloads 0
Drewno jako źródło alergenów i haptenów oraz przyczyna chorób zawodowych cz. IV
The applied tabular overview in part II part III and IV presents the current knowledge about wood as a source of allergens and haptens and the cause of occupational diseases a clear way. It is possible by paying a sustai...
Przetwarzanie żywności a alergia pokarmowa
Food processing is an integral part of our lives. Processing begins at the crop, then food is stored under different conditions. Various actions are aimed at prolonging its usefulness for consumption, as well as improvin...
Rola genów zegara biologicznego w astmie atopowej
The circadian clock is an endogenous system that synchronizes metabolic processes with the day-night cycle. The central and peripheral biological clocks are located in the suprachiasmatic nucleus in hypothalamus and in t...
Alergologia w Polsce w 2018 roku
Brak
Profilaktyka uczulenia na roztocze kurzu mieszkaniowego - rola nowoczesnego akarycydu Allergoff
Epidemiological, acarological and clinical data on allergy to mites are presented. Secondary prevention is based on the control of the mite allergy in allergic patients. Allergen elimination methods are based on the abil...